Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis

References

• MozaffarianDBenjaminEJGoASHeart Disease and Stroke Statistics-2016 Update: a Report From the American Heart AssociationCirculation20161334e38e6026673558
   PubMed Web of Science ®Google Scholar
• ChowdhuryPKehlDChoudharyRMaiselAThe use of biomarkers in the patient with heart failureCurr Cardiol Rep201315637223644993
   PubMed Web of Science ®Google Scholar
• BallingLGustafssonFCopeptin as a biomarker in heart failureBiomark Med20148684185425224940
   PubMed Web of Science ®Google Scholar
• HolwerdaDAA glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterizationEur J Biochem19722833343395079944
   PubMedGoogle Scholar
• DunserMWWenzelVMayrAJHasibederWRManagement of vasodilatory shock: defining the role of arginine vasopressinDrugs200363323725612534330
   PubMed Web of Science ®Google Scholar
• ZhangRLiuJZhangYLiuQLiTChengLAssociation between circulating copeptin level and mortality risk in patients with intracerebral hemorrhage: a systemic review and meta-analysisMol Neurobiol Epub201615
   Web of Science ®Google Scholar
• BolignanoDCabassiAFiaccadoriECopeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiologyClin Chem Lab Med201452101447145624940718
   PubMed Web of Science ®Google Scholar
• ViasusDDel Rio-PertuzGSimonettiAFBiomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysisJ Infect201672327328226777314
   PubMed Web of Science ®Google Scholar
• RaskovalovaTTwerenboldRCollinsonPODiagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysisEur Heart J Acute Cardiovasc Care201431182724562800
   PubMedGoogle Scholar
• TheiladeSRosenlundSHansenTWGotzeJPerssonFRossingPIncreased copeptin in plasma predicts mortality and renal outcome in patients with type 1 diabetesDiabetologia201558S541S542
   Web of Science ®Google Scholar
• ThenCKowallBLechnerAPlasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 studyActa Diabetol201552110311225011650
   PubMed Web of Science ®Google Scholar
• RamalhoAASilvaDCortez-DiasNCopeptin predicts long term prognosis in patients with worsening heart failureEur J Heart Fail201416276
   Web of Science ®Google Scholar
• ChoiKSKimHJChunHJPrognostic role of copeptin after stroke: a systematic review and meta-analysis of observational studiesSci Rep201551166526119473
   PubMed Web of Science ®Google Scholar
• De MarchisGMKatanMWeckACopeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk studyInt J Stroke20138321421822336226
   PubMed Web of Science ®Google Scholar
• PurroyFSuarezICambraySFarreJSanahujaJBenabdelhakICopeptin improves the prognostic models of early subsequent stroke after a transient ischemic attackInt J Stroke20151025124206581
   PubMed Web of Science ®Google Scholar
• StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) groupJAMA2000283152008201210789670
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• HigginsJPGreenSCochrane Handbook for Systematic Review of Interventions, Version 5.1.0CopenhagenThe Nordic Cochrane Center20112011
   Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• MorgenthalerNGStruckJJochbergerSDunserMWCopeptin: clinical use of a new biomarkerTrends Endocrinol Metab2008192434918291667
   PubMed Web of Science ®Google Scholar
• Serradeil-Le GalCWagnonJValetteGNonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligandsProg Brain Res200213919721012436936
   PubMed Web of Science ®Google Scholar
• ChatterjeeKNeurohormonal activation in congestive heart failure and the role of vasopressinAm J Cardiol2005959A8B13B15619386
   PubMed Web of Science ®Google Scholar
• BaumannGDingmanJFDistribution, blood transport, and degradation of antidiuretic hormone in manJ Clin Invest1976575110911161262458
   PubMed Web of Science ®Google Scholar
• RobertsonGLMahrEAAtharSSinhaTDevelopment and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasmaJ Clin Invest1973529234023524727463
   PubMed Web of Science ®Google Scholar
• JernbergTStridsbergMLindahlBUsefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarctionAm J Cardiol2002891646611779526
   PubMed Web of Science ®Google Scholar
• NickelCHBingisserRMorgenthalerNGThe role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency departmentBMC Med201210722264220
   PubMed Web of Science ®Google Scholar
• VoorsAAvon HaehlingSAnkerSDC-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL studyEur Heart J200930101187119419346228
   PubMed Web of Science ®Google Scholar
• MassonSLatiniRCarbonieriEThe predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trialEur J Heart Fail201012433834720097683
   PubMed Web of Science ®Google Scholar
• TentzerisIJaraiRFarhanSComplementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failureEur J Heart Fail201113772673321616953
   PubMed Web of Science ®Google Scholar
• MillerWLGrillDEStruckJJaffeASAssociation of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failureAm J Cardiol2013111688088523276468
   PubMed Web of Science ®Google Scholar
• SunHSunTMaBPrediction of all-cause mortality with copeptin in cardio-cerebrovascular patients: a meta-analysis of prospective studiesPeptides20156991825849342
   PubMed Web of Science ®Google Scholar
• ZhangZXuXNiHSmall studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological studyCrit Care2013171R223302257
   PubMed Web of Science ®Google Scholar
• StoiserBMortlDHulsmannMCopeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failureEur J Clin Invest2006361177177817032344
   PubMed Web of Science ®Google Scholar
• GegenhuberAStruckJDieplingerBComparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failureJ Card Fail2007131424917339002
   PubMed Web of Science ®Google Scholar
• NeuholdSHuelsmannMStrunkGComparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the diseaseJ Am Coll Cardiol200852426627218634981
   PubMed Web of Science ®Google Scholar
• MillerWLHartmanKAHodgeDOResponse of novel biomarkers to BNP infusion in patients with decompensated heart failure: a multimarker paradigmJ Cardiovasc Transl Res20092452653520560012
   PubMed Web of Science ®Google Scholar
• NeuholdSHuelsmannMStrunkGPrognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapyClin Chem201056112112619884490
   PubMed Web of Science ®Google Scholar
• PotockiMBreidthardtTMuellerACopeptin and risk stratification in patients with acute dyspneaCrit Care2010146R21321106053
   PubMed Web of Science ®Google Scholar
• AlehagenUDahlstromURehfeldJFGoetzeJPAssociation of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failureJAMA2011305202088209521610241
   PubMed Web of Science ®Google Scholar
• MaiselAXueYShahKIncreased 90-day mortality in patients with acute heart failure with elevated copeptin secondary results from the biomarkers in acute heart failure (BACH) studyCirc Heart Fail20114561362021765124
   PubMed Web of Science ®Google Scholar
• PeacockWFNowakRChristensonRShort-term mortality risk in emergency department acute heart failureAcad Emerg Med201118994795821906204
   PubMed Web of Science ®Google Scholar
• BallingLKistorpCSchouMPlasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic dosesJ Card Fail201218535135822555263
   PubMed Web of Science ®Google Scholar
• BosselmannHEgstrupMRossingKPrognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up studyInt J Cardiol2013170220220724182673
   PubMed Web of Science ®Google Scholar
• HolmstromASigurjonsdottirRHammarstenOPetzoldMGustafssonDFuMLXAn integrated multiple marker modality is superior to NT-proBNP alone in prognostic prediction in all-cause mortality in a prospective cohort of elderly heart failure patientsEur Geriatr Med201346365371
   Web of Science ®Google Scholar
• PozsonyiZForheczZGombosTKaradiIJanoskutiLProhaszkaZCopeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fractionHeart Lung Circ201524435936725618448
   PubMed Web of Science ®Google Scholar
• Long-haiWQi-songCFangXIAChaoFHai-junHEPingZPrognostic value of copeptin, big endothelin-1 and N-terminal pro-brain natriuretic peptide in patients with chronic heart failureMod Lab Med2015301646771
   Google Scholar